Zona de Prensa



Sirio Europe invest in advanced manufacturing and green technologies at Brandenburg site
15 de octubre 2020

Brandenburg, Germany, 15 October 2020: Sirio Europe – the leading European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO), part of the Sirio group – announces the completion of a major overhaul of its Brandenburg site with advanced manufacturing and green technologies. The company has installed new HVAC systems, individual drying chambers, vegetarian softgel manufacturing equipment and a block heat & power plant. The improvements were implemented as part of Sirio Europe’s continuous efforts to further improve the quality and sustainability of manufacturing.

 


“One of the reasons behind the investments was that we wanted to be at the forefront of implementing greener solutions and energy-efficient manufacturing for our pharma customers. So while implementing new equipment, we also explored how we can improve the plant’s sustainability.” commented Dominique Baum, Managing Director at Sirio Europe

The HVAC systems increase the plant’s manufacturing capacity while further reducing the risk of product contamination. Similarly, by using only individual drying chambers, the company can control the temperature of individual products, which is more energy-efficient and improves the softgel drying process. Additionally, a new vegetarian softgel manufacturing line has been installed – transferring technology from Sirio’s Guangzhou plant – in response to the growing demand for plant-based nutraceuticals.

But in line with the company commitment to increased sustainability, the site upgrades will be supported by an energy-efficient block heat & power station, which is estimated to increase power output by up to 50% through combined heat and power (CHP). The technology captures and recycles heat – otherwise lost as waste – into thermal energy to power the new manufacturing equipment.

Baum added: “Installing the heat block & power station is a huge business benefit in terms of reducing energy consumption. For example, softgel production uses a lot of energy as strict parameters need to be adhered to – through CHP we can now manufacture softgels at a lower cost. But installing the heat block was also the right thing to do in terms of looking at ways to make manufacturing as sustainable as possible”.

The new plant upgrades form just a small part of wider drive at the Sirio Group to implement the most sustainable manufacturing processes of any nutraceutical CDMO globally. For example, the company exclusively sources ingredients from certified, sustainable suppliers, and are members of a number of certified sustainability groups, including the Friends of the Sea (part of the World Sustainability Organisation) and Marine Stewardship Council.

 

 

About the Ayanda plant

Ayanda belongs to Sirio Europe, the  European based member of Sirio Group with more than 20 years of experience in contract manufacturing of nutraceutical and pharmaceutical private label softgel products, that not only comply with but exceed industry standards and expectations.

Ayanda’s core business is development and manufacturing of complex softgels containing up to 10 or more ingredients. The company has a strict focus on quality and is dedicated to exceeding global quality requirements.

 

Ayanda is a Pharma GMP approved site, holds IFS Food Standard and BRC certifications, both graded at highest score. Since sustainability matters more and more to customers and consumers, Ayanda is organic certified and holds two certificates for sustainable seafood: FOS (Friend of the Sea) and MSC (Marine Stewardship Council).

 

Since December 2016, Ayanda has been a SIRIO Group company, owned by Sirio Pharma Co. Ltd.

https://sirio-europe.com/


About SIRIO

Founded in 1993, Sirio Pharma Co., Ltd (SIRIO) is the leading global nutraceutical CDMO specialized in developing and manufacturing quality products including softgel, capsule, tablet, powder, gummy, oral liquid, probiotics and other dosage forms. The company has extensive capabilities with multiple manufacturing sites in China, as well as manufacturing facilities in Europe and marketing teams in the USA. SIRIO is devoted to offering one-stop solutions including product developing, manufacturing, packaging and logistics to its customers.

 

SIRIO is approved by TGA-GMP, NPA/UL GMP, BRC, UL's Management System 21 CFR Part 111, ISO 9001:2015 certification, and etc. Cooperating with many well-known nutraceutical companies, SIRIO is committed to providing products and service to customers all around the world.

https://en.siriopharm.com/

 

PR Contacts

De Facto Communications

Alex Heeley or Abdul Khalifeh

Contact: +44 203 735 8168 

a.heeley@defacto.co.uk / a.khalifeh@defacto.co.uk


Convocatoria:   - 28 de octubre 2020